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Disclosure  of  interest  or  conﬂict  of  interest?
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•Submission  of  an  article  in  an  international  journal  now
requires  systematic  completion  of  a  ‘‘disclosure  of  potential
conﬂicts  of  interest’’  form.  The  same  holds  true  for  national
and  international  podium  presentations,  also  subject  to  a
statement  disclosing  any  ﬁnancial  relations  the  speaker  and
co-authors  may  have  with  industry.  This  question,  by  no
means  a  minor  one,  regularly  comes  to  the  forefront  of
the  media  scene,  chieﬂy  in  affairs  relative  to  a  particu-
lar  medication  or  implantable  medical  device.  This  is  an
ethical  requirement  that  engages  the  responsibility  of  the
author,  the  co-authors,  and  the  institution  where  the  study
was  conducted,  as  well  as  the  journal’s  editorial  board.  It  is
because  the  Journal  has  an  important  responsibility  in  this
area  that  we  have  decided  to  request  all  the  OTSR  editors  to
declare  any  ﬁnancial  relations  they  may  have  with  industry.
Our  readers  will  have  access  to  this  information  through  the
OTSR-RCOT  secretarial  ofﬁces.
Why make the disclosure statement? How
should the disclosure be  made? What should
be disclosed?
The  ‘‘disclosure  of  potential  conﬂicts  of  interest’’  is  too
often  perceived  as  an  intrusion  on  an  author’s  professional,
even  personal,  life.  However,  it  is  anything  but  that.  The
term  ‘‘conﬂict  of  interest’’,  now  in  general  use,  also  con-
tributes  to  this  perception.  This  is  not  a  ‘‘conﬂict’’  but  ‘‘a
disclosure’’  intended  to  provide  transparency.  Collaboration
between  an  implant  manufacturer  and  surgeons  is  indispens-
able  and  healthy.  Manufacturers  could  not  develop  their
products  without  surgeons  and  surgeons  could  not  imple-
ment  their  projects  without  the  assistance  of  industry.  And
all  work  deserves  its  just  reward.
Nonetheless,  these  relationships  should  be  clear  and
transparent:  such  is  increasingly  the  case  in  the  formal-
ization  of  contracts  between  manufacturers  and  surgeons.
Relationships  should  also  be  disclosed  in  publications  report-
ing  the  resulting  studies.  It  goes  without  saying  that  the
reader’s  view  on  a  study  of  results  after  total  hip  arthro-
plasty  will  differ  depending  on  whether  or  not  the  author
is  a  promotor  of  the  implant.  This  information  is  at  least
1877-0568/$ – see front matter © 2012 Published by Elsevier Masson SAS
doi:10.1016/j.otsr.2012.05.001s  important  as  the  patients’  BMI  and  age,  the  type  of
steoarthritis,  the  study  design,  or  any  other  information
resented  in  the  Material  and  Methods  section,  in  the  assess-
ent  of  scientiﬁc  bias.
This  disclosure  form  should  therefore  be  completed  with
he  greatest  attention  and  precision.
hen should a disclosure be made?
wo  options  are  possible:  restrictive  or  open.
The  restrictive  option  consists  in  only  disclosing  the  inter-
sts  directly  and  exclusively  related  to  the  implants  or
edications  cited  in  the  article.  An  author  X  conducts  a
tudy  on  a  prosthesis  Y  and  has  a  relationship  with  the  same
anufacturer  for  a  prosthesis  Z.  In  this  restrictive  option,
e  declares  no  conﬂict  of  interest.  This  is  an  option  spon-
aneously  followed  by  many  authors.  However,  it  provides
ittle  information  and  obviously  does  not  guarantee  the  inde-
endence  of  the  study.
This  is  why  OTSR-RCOT  wishes  to  follow  the  guidelines
f  the  International  Committee  of  Medical  Journal  Edi-
ors  (ICMJE,  www.icmje.org/ethical 4conﬂicts.html),  which
pens  the  ﬁeld  of  disclosure.
Any  ﬁnancial,  personal,  or  institutional  relationship  in
he  36  months  preceding  the  submission,  related  to  ‘‘the
ubject’’  of  the  article  and  not  only  ‘‘the  implants  or  the
edications’’  cited  in  the  article  should  be  declared.  The
ollowing  are  two  illustrative  examples:
 a study  on  the  treatment  of  stiffness  after  total  shoul-
der  arthroplasty  (whatever  model  or  models  are  used)
requires  a  disclosure  if  the  author  has  interests  with  a
shoulder  prosthesis  model,  even  if  it  is  not  cited  in  the
article;
 a study  on  the  poor  results  of  a  total  knee  prosthesis
X  requires  a  disclosure  if  the  author  has  interests  with
another  prosthesis  model,  whether  or  not  it  is  manufac-
tured  by  the  same  manufacturer,  and  even  more  so  if  it  is
produced  by  another  manufacturer.
A  multiplicity  of  examples  could  be  cited.
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hat should be disclosed?
inancial  relationships  come  in  many  forms  (they
an  be  found  in  the  author  recommendations  of  the
ournal  or  in  the  glossary  established  by  the  ICMJE
ww.icmje.org/coi glossary.pdf): stock  holdings  in  a
ompany, royalties,  fees,  salary,  a  budget  speciﬁc  to  the
tudy,  but  also  an  invitation  as  a  speaker  or  auditor,  payment
f  travel  expenses,  etc.  These  can  apply  to  the  author,
ne  or  all  of  the  coauthors,  and  ﬁnally  to  the  institution.Editorial
TSR-RCOT  would  like  all  of  these  relationships  to  be
isclosed.
We  thank  you  in  advance  for  taking  into  consideration
hese  concepts,  which,  as  the  reader  will  have  under-
tood,  have  no  further  objective  than  to  ensure  the  greatest
ossible  transparency  between  the  journal’s  authors  and
eaders.P. Beauﬁls
Editor  in  chief  OTSR-RCOT
E-mail  address:  rco@sofcot.fr
